nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ISN Nexus Symposium 2016 Highlights: Translational Immunology in Kidney Disease, Berlin, Germany, April 14–17, 2016
|
|
|
2016 |
1 |
4S |
p. A1- 1 p. |
artikel |
2 |
P22 A NOVEL METHOD FOR HIGH-THROUGHPUT DETECTION AND QUANTIFICATION OF NEUTROPHIL EXTRACELLULAR TRAPS REVEALS ROS-INDEPENDENT NET RELEASE WITH IMMUNE COMPLEXES
|
Kraaij, T. |
|
2016 |
1 |
4S |
p. S11- 1 p. |
artikel |
3 |
P04 A NOVEL MOUSE MODEL OF MEMBRANOUS NEPHROPATHY INDUCED WITH HETEROLOGOUS RABBIT ANTI-THSD7A ANTIBODIES
|
Tomas, N. |
|
2016 |
1 |
4S |
p. S2- 1 p. |
artikel |
4 |
P01 ANTI MICA (MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I RELATED CHAIN A) ANTIBODY, WHETHER TO TREAT OR AVOID IN RENAL TRANSPLANTATION?
|
Godhani, U. |
|
2016 |
1 |
4S |
p. S1- 1 p. |
artikel |
5 |
P37 ASSESING THE ROLE OF B7-1 IN DIABETIC NEPHROPATHY
|
Herrera, M. |
|
2016 |
1 |
4S |
p. S17- 1 p. |
artikel |
6 |
P08 BASOPHIL DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS
|
Aljadi, Z. |
|
2016 |
1 |
4S |
p. S4- 1 p. |
artikel |
7 |
P21 BETA-HYDROXYBUTYRATE INHIBITS NLRP3-MEDIATED INFLAMMATION AND DELAYS PROGRESSIVE RENAL FAILURE DURING PRIMARY HYPEROXALURIA RELATED KIDNEY STONE DISEASE
|
Kumar, S.V. |
|
2016 |
1 |
4S |
p. S10-S11 2 p. |
artikel |
8 |
P36 CATHEPSIN-S INHIBITION HAS A DUAL THERAPEUTIC EFFECT ON THE SYSTEMIC AND PERIPHERAL PATHOMECHANISMS OF LUPUS NEPHRITIS
|
Kumar VR, S. |
|
2016 |
1 |
4S |
p. S17- 1 p. |
artikel |
9 |
P11 CHARACTERIZING THE IMMUNE PROFILE OF SERIAL KIDNEY BIOPSIES DIFFERENTIATES TREATMENT RESPONDERS FROM NON-RESPONDERS IN LUPUS NEPHRITIS
|
Parikh, S. |
|
2016 |
1 |
4S |
p. S5-S6 2 p. |
artikel |
10 |
P13 CLINICAL SIGNIFICANCE OF DONOR SPECIFIC ANTIBODIES (DSA) IN LIVING RELATED RENAL ALLOGRAFT TRANSPLANT RECIPIENTS: A SINGLE CENTRE EXPERIENCE
|
Bhargava, V. |
|
2016 |
1 |
4S |
p. S6-S7 2 p. |
artikel |
11 |
P09 CYTOGENETIC CHANGES IN PERIPHERAL BLOOD LYMPHOCYTES OF PATIENTS ON HEMODIALYSIS INFECTED WITH HEPATITIS C
|
Khil, M. |
|
2016 |
1 |
4S |
p. S4-S5 2 p. |
artikel |
12 |
P34 DUAL BLOCKADE OF THE HOMEOSTATIC CHEMOKINE CXCL12 AND THE PRO-INFLAMMATORY CHEMOKINE CCL2 IS AS EFFECTIVE AS CYCLOPHOSPHAMIDE IN PROLIFERATIVE LUPUS NEPHRITIS
|
Devarapu, S.K. |
|
2016 |
1 |
4S |
p. S16- 1 p. |
artikel |
13 |
P02 ENHANCED IMMUNOPATHOLOGY EVALUATION OF HUMAN RENAL BIOPSIES USING MULTICOLOR FLOW CYTOMETRY AND CYTOKINE ANALYSIS: A FOCUS ON TRANSPLANTED KIDNEYS
|
Muczynski, K. |
|
2016 |
1 |
4S |
p. S1- 1 p. |
artikel |
14 |
P18 ER-STRESS AND LOSS OF GRP78 EXPRESSION PROVIDES A LINK BETWEEN RENAL ISCHEMIA/ REPERFUSION INJURY AND THE URINARY METABOLOME
|
van Kooten, C. |
|
2016 |
1 |
4S |
p. S9- 1 p. |
artikel |
15 |
P25 GENERATION, PHENOTYPE AND FUNCTION OF EX VIVO INDUCED HUMAN REGULATORY T CELLS
|
Fierro, A. |
|
2016 |
1 |
4S |
p. S12- 1 p. |
artikel |
16 |
P20 HERPES VIRUSES ORAL SHEDDING IN CHRONIC RENAL PATIENTS
|
Pallos, D. |
|
2016 |
1 |
4S |
p. S10- 1 p. |
artikel |
17 |
P48 HUMAN CD362+ MESENCHYMAL STROMAL CELL THERAPY FOR DIABETIC KIDNEY DISEASE IN LEPR DB/DB MICE
|
Devarapu, S.K. |
|
2016 |
1 |
4S |
p. S22- 1 p. |
artikel |
18 |
P10 IDENTIFICATION OF BIOMARKER CANDIDATES AND THERAPEUTIC TARGETS USING TRANSCRIPTOME-DRIVEN APPROACH
|
V.N.S.S.L.Z.K.S., |
|
2016 |
1 |
4S |
p. S5- 1 p. |
artikel |
19 |
P05 IDENTIFICATION OF GLYCOSAMINOGLYCANS THAT SPECIFICALLY INHIBIT THE LECTIN PATHWAY OF COMPLEMENT
|
Talsma, D. |
|
2016 |
1 |
4S |
p. S2-S3 2 p. |
artikel |
20 |
P23 IL-33 ELICITS INNATE LYMPHOID CELLS AND ALTERNATIVELY ACTIVATED MACROPHAGES THAT REDUCE RENAL ISCHEMIC-REPERFUSION INJURY
|
Cao, Q. |
|
2016 |
1 |
4S |
p. S11- 1 p. |
artikel |
21 |
P40 IL-17F PROMOTES TISSUE INJURY IN AUTOIMMUNE KIDNEY DISEASES
|
Paust, H.J. |
|
2016 |
1 |
4S |
p. S19- 1 p. |
artikel |
22 |
P41 IL-33-MEDIATED EXPANSION OF TYPE 2 INNATE LYMPHOID CELLS AMELIORATES PROGRESSIVE GLOMERULOSCLEROSIS
|
Becker, M. |
|
2016 |
1 |
4S |
p. S19- 1 p. |
artikel |
23 |
P45 IL-2 THERAPY REDUCES RENAL INFLAMMATION AND CELLULAR ACTIVITY OF INTRARENAL CD4+ CONVENTIONAL T CELLS IN LUPUS PRONE MICE WITH ACTIVE LUPUS NEPHRITIS
|
Rose, A. |
|
2016 |
1 |
4S |
p. S20-S21 2 p. |
artikel |
24 |
P33 IMMUNOSUPPRESSIVE TREATMENT ALTERS SECRETION OF ILEAL ANTIMICROBIAL PEPTIDES AND GUT MICROBIOTA, AND FAVORS SUBSEQUENT COLONIZATION BY UROPATHOGENIC ESCHERICHIA COLI
|
Tourret, J. |
|
2016 |
1 |
4S |
p. S16- 1 p. |
artikel |
25 |
P35 INCREASED RECRUITMENT OF HUMAN LYMPHOCYTE SUBSETS IN RENAL FIBROSIS AND CHRONIC KIDNEY DISESASE
|
Healy, H. |
|
2016 |
1 |
4S |
p. S16-S17 2 p. |
artikel |
26 |
P16 INTERCELLULAR ADHESION MOLECULE-1 K469E(A/G) POLYMORPHISM AND ITS EFFECTS IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY
|
Gu, H. |
|
2016 |
1 |
4S |
p. S8- 1 p. |
artikel |
27 |
P31 INTESTINAL TH17 CELLS DRIVE RENAL TISSUE INJURY IN CRESCENTIC GLOMERULONEPHRITIS
|
Krebs, C. |
|
2016 |
1 |
4S |
p. S15- 1 p. |
artikel |
28 |
P17 INTRAVASCULAR NEUTROPHIL EXTRACELLULAR TRAP (NET) RELEASE PROMOTE VASCULAR INJURY AND TUBULAR NECROSIS UPON ISCHEMIA/REPERFUSION INJURY (IRI) OF KIDNEY
|
Nakazawa, D. |
|
2016 |
1 |
4S |
p. S8-S9 2 p. |
artikel |
29 |
P29 LEARNING ABOUT HUMAN KIDNEY IMMUNOLOGY FROM THERAPEUTIC MONOCLONAL ANTIBODY-INDUCED KIDNEY INJURY: EFFECT OF PD1 BLOCKADE
|
Muczynski, K. |
|
2016 |
1 |
4S |
p. S14- 1 p. |
artikel |
30 |
P46 LOW DOSE CYCLOPHOSPHAMIDE AS AN INDUCTION AGENT IN PROLIFERATIVE LUPUS NEPHRITIS PATIENTS IN CENTRAL INDIA - AN AFFORDABLE & VIABLE OPTION
|
Balwani, M. |
|
2016 |
1 |
4S |
p. S21- 1 p. |
artikel |
31 |
P44 MARKERS OF OXIDATIVE STRESS IN PATIENTS OF SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT LUPUS NEPHRITIS
|
Rathi, M. |
|
2016 |
1 |
4S |
p. S20- 1 p. |
artikel |
32 |
P14 MIF IS AN ENDOGENOUS FIBROSIS LIMITING FACTOR IN PROGRESSIVE KIDNEY DISEASES
|
Djudjaj, S. |
|
2016 |
1 |
4S |
p. S7- 1 p. |
artikel |
33 |
P06 OFATUMUMAB FOR B CELL DEPLETION THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ARE INTOLERANT OF RITUXIMAB
|
McAdoo, S. |
|
2016 |
1 |
4S |
p. S3- 1 p. |
artikel |
34 |
P32 PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR ALPHA NEGATIVELY REGULATES ANTIBODY- MEDIATED GLOMERULONEPHRITIS
|
Sugiyama, Y. |
|
2016 |
1 |
4S |
p. S15-S16 2 p. |
artikel |
35 |
P12 PROTEOSTASIS AS A THERAPEUTIC TARGET IN GLOMERULAR INJURY
|
Cybulsky, A. |
|
2016 |
1 |
4S |
p. S6- 1 p. |
artikel |
36 |
P26 RESPONSE TO USE OF CNI IN STEROID RESISTANT AND FREQUENTLY RELAPSING NEPHROTIC SYNDROME IN WESTERN INDIA
|
Balwani, M. |
|
2016 |
1 |
4S |
p. S12-S13 2 p. |
artikel |
37 |
P03 RITUXIMAB IN DIFFICULT PAEDIATRIC NEPHROTIC SYNDROME: AN ACCOUNT FROM EASTERN INDIA
|
Sinha, R. |
|
2016 |
1 |
4S |
p. S1-S2 2 p. |
artikel |
38 |
P27 ROLE OF CORTICOSTEROID THERAPY IN IgA NEPHROPATHY - WHERE DO WE STAND?
|
Nagaraju, S.P. |
|
2016 |
1 |
4S |
p. S13- 1 p. |
artikel |
39 |
P24 RORÎ3t+ FOXP3+ BITREGS PROMOTE LUPUS NEPHRITIS VIA IL-17 SECRETION AND SUPPRESSION OF TH2 RESPONSES
|
Kluger, M. |
|
2016 |
1 |
4S |
p. S11-S12 2 p. |
artikel |
40 |
P39 SHARED AND ENDORGAN SPECIFIC TRANSCRIPTIONAL NETWORKS IN SKIN VERSUS KIDNEY BIOPSIES IN SYSTEMIC LUPUS
|
Berthier, C.C. |
|
2016 |
1 |
4S |
p. S18- 1 p. |
artikel |
41 |
P07 SHOULD PATIENTS UNDERGOING RENAL TRANSPLANT WITHOUT INDUCTION WITH BIOLOGIC AGENTS, RECEIVE CYTOMEGALOVIRUS CHEMOPROPHYLAXIS?
|
Rangaswamy, D. |
|
2016 |
1 |
4S |
p. S3-S4 2 p. |
artikel |
42 |
P38 SNP PROFILING OF KIDNEY TRANSPLANT PATIENTS: HIGHLIGHTING THE DIFFERENCES IN THE GENETICAL BACKGROUND TO MAXIMALIZE IMMUNOSUPPRESSIVE THERAPIES
|
Scalzotto, E. |
|
2016 |
1 |
4S |
p. S18- 1 p. |
artikel |
43 |
P28 TAC-TIC USE OF TACROLIMUS-BASED REGIMENS IN LUPUS NEPHRITIS
|
Kraaij, T. |
|
2016 |
1 |
4S |
p. S13-S14 2 p. |
artikel |
44 |
P47 THE ANTIRENAL AUTOREACTIVE CD4+ T CELL RESPONSE IN HUMAN LUPUS NEPHRITIS
|
Tesch, S. |
|
2016 |
1 |
4S |
p. S21-S22 2 p. |
artikel |
45 |
P15 THE EFFECT OF PEPTIGYLARGININE DEIMINASE 4 INHIBITOR ON MPO-ANCA PRODUCTION IN MOUSE MODEL
|
Kusunoki, Y. |
|
2016 |
1 |
4S |
p. S7-S8 2 p. |
artikel |
46 |
P43 THE ROLE OF B7.1 AND suPAR IN PODOCYTE INJURY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS
|
Vincenti, F. |
|
2016 |
1 |
4S |
p. S20- 1 p. |
artikel |
47 |
P19 TISSUE PRIMING OF PLASMACYTOID DENDRITIC CELLS ENHANCES THEIR PHAGOCYTOSIS AND LOWERS THE THRESHOLD FOR SUBSEQUENT TOLL-LIKE RECEPTOR 9 ACTIVATION
|
Ruben, J. |
|
2016 |
1 |
4S |
p. S9-S10 2 p. |
artikel |
48 |
P42 URINARY CELL SIGNATURE OF PATIENTS WITH ACUTE KIDNEY INJURY
|
Langhans, V. |
|
2016 |
1 |
4S |
p. S19-S20 2 p. |
artikel |
49 |
P30 VITAMIN D RECEPTOR ACTIVATION REDUCES INFLAMMATORY CYTOKINES AND PLASMA MICRORNAS IN MODERATE CHRONIC KIDNEY DISEASE–A RANDOMIZED TRIAL
|
Mansouri, L. |
|
2016 |
1 |
4S |
p. S14-S15 2 p. |
artikel |